基于MRI的子宫间叶性肿瘤风险分层新方法
该双中心回顾性观察性队列研究纳入455例子宫间叶性肿瘤女性,外部验证既往MRI专家共识算法并评估改良评分系统的诊断准确性;改良算法加入肿瘤边缘不规则、绝经状态、与膀胱比较的DW信号及ADC阈值1.23×10⁻³ mm²/sec后,准确率98%、敏感度83.3%、特异度98.6%,显著优于初始算法。
要点
- 改良算法5项标准:T2W信号、DW信号、ADC阈值1.23×10⁻³ mm²/sec、肿瘤边缘、绝经状态。
- 改良算法准确率98%,敏感度83.3%,特异度98.6%,仅漏诊3例(2例STUMP、1例平滑肌肉瘤)。
核心结论
- 改良MR影像评估算法提高恶性子宫间叶性肿瘤的真阳性诊断,有效区分良性平滑肌瘤。
- 新算法可对潜在恶性子宫间叶性肿瘤进行适当分诊,减轻子宫平滑肌肉瘤患者粉碎术相关风险。
- 结合多因素分析5项标准的新算法可区分良恶性子宫间叶性肿瘤,并构建有助于典型与非典型子宫病变管理的分层评分。
研究设计与样本
- 双中心回顾性观察性队列研究,经机构伦理委员会批准并豁免知情同意(CRM-2405-410),时间范围为2018年1月至2023年12月。
- 纳入病理诊断为子宫间叶性肿瘤且在此之前六个月内行盆腔MRI的女性,共455例(平均年龄43岁,范围15-82岁)。
- 由两名分别有6年和3年妇科MRI经验的放射科医生盲法记录临床和MR标准,评估多项MR特征。
- 连续变量采用Mann-Whitney检验,分类变量采用Fisher精确检验;计算预测恶性的比值比(OR)及95%置信区间和P值。
关键影像表现/征象
- 初始标准包括盆腔淋巴结增大、T2W信号强度、与子宫内膜比较的DW信号强度及ADC阈值0.9×10⁻³ mm²/sec。
- 改良算法新增肿瘤边缘不规则、绝经状态、与膀胱比较的DW信号及ADC阈值1.23×10⁻³ mm²/sec。
- 队列中437例平滑肌瘤、2例STUMP(0.4%)、16例恶性子宫间叶性肿瘤(3.5%)。
诊断标准与关键数值
- 改良算法准确分类446/455例(准确率98%,95%CI 97.1%-98.1%),仅漏诊3例肿瘤(2例STUMP、1例平滑肌肉瘤),敏感度83.3%(95%CI 79-88),特异度98.6%(95%CI 98-99)。
- 新算法显著提高准确率(p=0.001),并构建5类评分系统。
临床应用与阅片要点
- 改良MR影像评估算法可提高恶性子宫间叶性肿瘤的真阳性诊断,并有效区分良性平滑肌瘤。
- 新算法可对潜在恶性子宫间叶性肿瘤进行适当分诊,减轻子宫平滑肌肉瘤患者粉碎术相关风险。
- 新算法构建的分层评分有助于典型与非典型子宫病变的管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Surgery for uterine mesenchymal tumors is common in gynecology. Preoperative diagnosis of malignant tumors can lead to appropriate management for the lesions.
PURPOSE: This study aims to externally validate a previous MRI-based expert consensus algorithm and evaluate the potential modification of MR-based scoring system's accuracy in diagnosing uterine mesenchymal tumors (UMT).
MATERIAL AND METHODS: With institutional ethics committee approval and a waiver of informed consent (CRM-2405-410), a bicentric retrospective observational cohort study was conducted from January 2018 to December 2023. The study included women with a pathological diagnosis of uterine mesenchymal tumor following a pelvic MRI within six months. Clinical and MR criteria were blindly recorded by two radiologists (6- and 3-years' experience in gynaecological MR imaging) who assessed several MR features. Continuous variables were analyzed using a Mann-Whitney test, and categorical variables using Fisher's exact test. Odds ratios (OR) for predicting malignancy were calculated with 95% confidence intervals and p-values.
RESULTS: The cohort included 455 women (mean age: 43 years, range: 15-82 years) with mesenchymal tumors: 437 leiomyomas, 2 STUMPs (0.4 %), and 16 malignant UMT (3.5 %). Using initial criteria (enlarged pelvic lymph nodes, T2W signal intensity, DW signal intensity compared to endometrium, and ADC cutoff value of 0.9 × 10-3 mm2/sec), the model accurately classified 421 out of 455 cases (Accuracy: 92,5% (CI 93,1-94,3) and missed with 7 tumors (5 leiomyosarcomas, 2 STUMP). The sensitivity was 61.1 % (CI95% 38.5-83.6) and specificity was 93.8 % (CI95% 91.2-95.8) A modified algorithmic approach added "irregular tumor margins" and menopausal status, modified DW signal compared to bladder, and an elevated ADC cutoff value of 1.23 × 10-3 mm2/sec, improving classification to 446 out of 455 cases (Accuracy: 98 % (CI95% 97.1 %-98.1 %) with only 3 missed tumors (2 STUMP and one leiomyosarcoma). The sensitivity was 83.3 % (CI95% 79-88) and specificity was 98.6 % (CI95% 98-99). The new algorithm significantly improved accuracy (p = 0.001), allowing the development of a 5-category scoring system.
CONCLUSION: Modified MR imaging evaluation algorithms increase true positive diagnosis of malignant UMTs leading to effective differentiation from benign leiomyomas. The new algorithm can allow for appropriate triage of potentially malignant UMTs, alleviating risk associated with morcellation in patients with uterine leiomyosarcoma.
SUMMARY: Our study demonstrates that combining 5 criteria based on multivariate analysis in a new algorithm (T2W signal, DW signal, ADC cut off value of 1.23 x 10-3 mm2/sec, tumor margins and menopausal status) allows us to distinguish benign from malignant uterine mesenchymal tumors with an accuracy of 98 % (CI95% 97,1%-98,1%), a sensitivity of 83.3 % (CI95% 79-88) and a specificity of 98.6 % (CI95% 98-99). This model allows to build a stratification score that would help in the management of typical and atypical uterine lesions.
引用
- Zlotykamien-Taieb E, Gherman D, Rouhban RA, et al. Novel approach to MRI based risk stratification of uterine myometrial lesions. Eur J Radiol. 2025. PMID: 40273759. doi:10.1016/j.ejrad.2025.112126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。